An established specialist in reproductive endocrinology, Dr. Jonathan Kort thinks Orchid represents the future of preventative medicine.
- Dr. Jonathan Kor, MD, MBA, is a reproductive endocrinologist practicing at RMA of Northern California and is on the editorial board of the leading reproductive journal, Fertility and Sterility.
What Dr. Jonathan Kort has to say about Orchid
**“**Orchid’s preconception genetic testing offers the next generation of preventative medicine and improved generational health. This platform offers the potential for at-risk families to reduce their childrens’ genetic predisposition to serious health conditions, improving health for many future generations.”
— Dr. Jonathan Kort, MD, MBA
Dr. Jonathan Kort’s Bio
Dr. Jonathan Kort is an established specialist in reproductive endocrinology and the author of many medical publications and textbook chapters in the field of infertility science. He sits on the editorial board of Fertility and Sterility, has published textbook chapters on gamete and embryo selection, and was the recipient of the Stanford Child Health Research Institute Grant (2017), which helped develop new ways of using preimplantation genetic screening for embryo selection. Dr. Kort completed his Reproductive Endocrinology and Infertility fellowship at Stanford University Hospital, where he conducted cutting-edge research on non-invasive measurements of eggs to predict their future development potential, as well as research in genetic screening. During his time at Stanford he also completed training in embryology and is certified as a technical supervisor in embryology and andrology. He completed his OB GYN residency at Stanford University Hospital, during which he completed original research into egg freezing, the impact of weight loss on fertility treatment, and ovarian reserve. Dr. Kort’s clinical focus areas include diminished ovarian reserve, hypothalamic amenorrhea, Polycystic Ovary Syndrome (PCOS), reproductive surgery, and gamete/embryo selection.
